Investing Profile

Vincent Brichard

Investor

Venture Partner at EQT Group

Brussels

Your Intro Paths to Vincent Brichard

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Vincent is a member of

Moving Capital Network

962 CONNECTIONS

Harvard Business School Network

159 CONNECTIONS

GSK Network

45 CONNECTIONS

EQT Group Network

35 CONNECTIONS

GlaxoSmithKline Network

19 CONNECTIONS

Find Vincent Brichard on

Current Investing Position

EQT Group Venture Partner

Investment Range

$1M - $5.0M

Sweet Spot

$1.5M

Investments On Record

Vincent Brichard is on these Sector & Stage Rankings

BioTech (Series B)BioTech (Seed)Health & Hospital Services (Series B)Health IT (Series A)BioTech (Series A)Health & Hospital Services (Series A)Digital Health (Series B)Health IT (Seed)Health IT (Series B)Digital Health (Series A)Digital Health (Seed)Health & Hospital Services (Seed)

Vincent Brichard's Investments On Record (5)

Company	StageDateRound Size	Total Raised
FoRx Therapeutics	Series ADec 2025$50M Series AJun 2025$49M SeedApr 2020$11M	$110M
Co-investors: Florian Müllershausen (Novartis Venture Fund), Therese Liechtenstein (MDC Ventures (formerly KBS Ventures)), Vincent Ossipow (Omega Funds), Denis Patrick (Pfizer Venture Investments)
ATB Therapeutics	Series ANov 2024$57M	$57M
Co-investors: John de Koning (LSP)
Minervax	Series UnknownOct 2023$57M	$140M
Co-investors: Kabeer Aziz (Adjuvant Capital), Christopher Gagliardi (Sanofi Ventures), Veronica Gambillara Fonck (Pureos Bioventures)
ImCheck Therapeutics	Series CJun 2022$100M Series BDec 2019$53M	$180M
Co-investors: Klaus Breiner (Pureos Bioventures), Rémi Droller (Financial Services, Financial Technology, and Business Services), Michael Baran (Pfizer Venture Investments), Dr. Regina Hodits (Wellington Partners), Raphael Wisniewski (Andera Partners), Florent Gros (Earlybird Venture Capital)
Egle Therapeutics	Series AOct 2021$47M	$47M
Co-investors: Felice Verduyn - van Weegen (EQT Group), Jacques Mizrahi (Bioqube Ventures)

Vincent Brichard's Experience

PHD Ludwig Cancer ResearchPresent

Medical Oncology Department Institut CuriePresent

Professor of Oncology Faculté de philosophie, arts et lettres @UCLouvainPresent

Senior Executive Vice President GlaxoSmithKlinePresent

Senior Executive Vice President GSKPresent

MBA Harvard Business SchoolPresent

Vice-President Oncology Celyad OncologyPresent

Scientific & Investment Advisory Board Fournier-Majoie FoundationPresent

Independent Board member ethernaPresent

Independent Board member atbtherapeuticsPresent

Chairman of the Board Moving CapitalPresent

Professor Advanced Master in Biotechnology - Solvay Solvay Lifelong Learning | Solvay Brussels School of Economics & ManagementPresent

Founder & CEO VIANOVA srlPresent

Venture Partner EQT GroupPresent

Co-founder&CEO PARACRINE THERAPEUTICSPresent

Venture Partner EQT Life Sciences2016 - 2022

Vincent Brichard's Education

Université catholique de Louvain MD oncology

Investors who invest with Vincent Brichard

Scouts & Angels Affiliated With Vincent Brichard